Literature DB >> 3444375

A metabolite of an antineoplastic ether phospholipid may inhibit transmembrane signalling via protein kinase C.

W J van Blitterswijk1, R L van der Bend, I M Kramer, A J Verhoeven, H Hilkmann, J de Widt.   

Abstract

In our search for the mechanisms by which the drug 1-O-alkyl-2-O-methylglycero-3-phosphocholine (AMG-PC) inhibits tumor growth and metastasis, we have detected a metabolite, 1-O-alkyl-2-O-methylglycerol (AMG), in membranes of MO4 mouse fibrosarcoma cells grown in the presence of the drug. Synthetic AMG inhibited the activation of highly purified human protein kinase C by diacylglycerol in the presence of phosphatidylserine. Furthermore, AMG also inhibited the receptor-specific binding of 3H-phorbol-12,13-dibutyrate to human HL-60 promyeloid leukemia cells in a dose-dependent fashion. AMG-PC was not effective or much less so in these assays. We suggest that interaction of the metabolite AMG with protein kinase C may inhibit stimulus-response coupling in tumor cells and may thus potentially contribute to the mechanism by which AMG-PC exerts its anticancer activities.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3444375     DOI: 10.1007/BF02535541

Source DB:  PubMed          Journal:  Lipids        ISSN: 0024-4201            Impact factor:   1.880


  20 in total

1.  Polyclonal antibodies to phospholipid/Ca2+-dependent protein kinase and immunocytochemical localization of the enzyme in rat brain.

Authors:  P R Girard; G J Mazzei; J G Wood; J F Kuo
Journal:  Proc Natl Acad Sci U S A       Date:  1985-05       Impact factor: 11.205

2.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

3.  Calculator programs for computing the composition of the solutions containing multiple metals and ligands used for experiments in skinned muscle cells.

Authors:  A Fabiato; F Fabiato
Journal:  J Physiol (Paris)       Date:  1979

4.  Calcium-activated, phospholipid-dependent protein kinase (protein kinase C) from rat brain.

Authors:  U Kikkawa; R Minakuchi; Y Takai; Y Nishizuka
Journal:  Methods Enzymol       Date:  1983       Impact factor: 1.600

5.  Receptor-mediated modulation of human monocyte, neutrophil, lymphocyte, and platelet function by phorbol diesters.

Authors:  B J Goodwin; J B Weinberg
Journal:  J Clin Invest       Date:  1982-10       Impact factor: 14.808

6.  Quantitative measurement of sn-1,2-diacylglycerols present in platelets, hepatocytes, and ras- and sis-transformed normal rat kidney cells.

Authors:  J Preiss; C R Loomis; W R Bishop; R Stein; J E Niedel; R M Bell
Journal:  J Biol Chem       Date:  1986-07-05       Impact factor: 5.157

7.  Stereospecificity of diacylglycerol for stimulus-response coupling in platelets.

Authors:  H Nomura; K Ase; K Sekiguchi; U Kikkawa; Y Nishizuka; Y Nakano; T Satoh
Journal:  Biochem Biophys Res Commun       Date:  1986-11-14       Impact factor: 3.575

8.  Antiinvasive effect of racemic 1-O-octadecyl-2-O-methylglycero-3-phosphocholine on MO4 mouse fibrosarcoma cells in vitro.

Authors:  G A Storme; W E Berdel; W J van Blitterswijk; E A Bruyneel; G K De Bruyne; M M Mareel
Journal:  Cancer Res       Date:  1985-01       Impact factor: 12.701

9.  Cytotoxicity and metabolism of alkyl phospholipid analogues in neoplastic cells.

Authors:  D R Hoffman; L H Hoffman; F Snyder
Journal:  Cancer Res       Date:  1986-11       Impact factor: 12.701

10.  Influence of implantation site of MO4 cell aggregates on the formation of metastases.

Authors:  C Meyvisch; M Mareel
Journal:  Invasion Metastasis       Date:  1982
View more
  15 in total

1.  Characterization of an HL-60 cell variant resistant to the antineoplastic ether lipid 1-O-octadecyl-2-O-methyl-rac-glycero-3-phosphocholine.

Authors:  G W Small; J C Strum; L W Daniel
Journal:  Lipids       Date:  1997-07       Impact factor: 1.880

Review 2.  Glycosidated phospholipids: uncoupling of signalling pathways at the plasma membrane.

Authors:  Kerstin Danker; Werner Reutter; Geo Semini
Journal:  Br J Pharmacol       Date:  2010-03-19       Impact factor: 8.739

3.  Synthesis and biological evaluation of ether-linked derivatives of phosphatidylinositol.

Authors:  K S Ishaq; M Capobianco; C Piantadosi; A Noseda; L W Daniel; E J Modest
Journal:  Pharm Res       Date:  1989-03       Impact factor: 4.200

4.  Sensitization of human umbilical vein endothelial cells to Shiga toxin: involvement of protein kinase C and NF-kappaB.

Authors:  C B Louise; M C Tran; T G Obrig
Journal:  Infect Immun       Date:  1997-08       Impact factor: 3.441

5.  Role of the host tissue in the anti-invasive activity of the alkyllysophospholipid, ET-18-OCH3, in vitro.

Authors:  D C Schallier; E A Bruyneel; G A Storme; M M Mareel
Journal:  Clin Exp Metastasis       Date:  1991 Nov-Dec       Impact factor: 5.150

6.  Derivatives of di-O-octanoylglycerol and mono-O-octylglycerol as modulators of protein kinase C and diacylglycerol kinase activities.

Authors:  J Goddat; H Coste; I Vilgrain; E Chambaz; H Driguez
Journal:  Lipids       Date:  1992-05       Impact factor: 1.880

7.  ATP-dependent and ATP-independent pathways of exocytosis revealed by interchanging glutamate and chloride as the major anion in permeabilized mast cells.

Authors:  Y Churcher; B D Gomperts
Journal:  Cell Regul       Date:  1990-03

8.  Accumulation of an alkyl lysophospholipid in tumor cell membranes affects membrane fluidity and tumor cell invasion.

Authors:  W J van Blitterswijk; H Hilkmann; G A Storme
Journal:  Lipids       Date:  1987-11       Impact factor: 1.880

9.  Metabolism of ether phospholipids and analogs in neoplastic cells.

Authors:  E A Fleer; C Unger; D J Kim; H Eibl
Journal:  Lipids       Date:  1987-11       Impact factor: 1.880

10.  Synergistic enhancement of the antiproliferative activity of cis-diamminedichloroplatinum(II) by the ether lipid analogue BM41440, an inhibitor of protein kinase C.

Authors:  J Hofmann; F Ueberall; L Posch; K Maly; D B Herrmann; H Grunicke
Journal:  Lipids       Date:  1989-04       Impact factor: 1.880

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.